Description: Prestige Brands Holdings, Inc., through its subsidiaries, engages in the marketing, sale, and distribution of over-the-counter healthcare and household cleaning products in North America and internationally. It operates through two segments, Over-The-Counter Healthcare and Household Cleaning. The Over-The-Counter Healthcare segment offers a portfolio of OTC products under 14 primary OTC brands, including Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Little Remedies pediatric healthcare products, The Doctor's brand of oral care products, Efferdent and Effergrip denture products, Luden's cough drops, PediaCare pediatric healthcare products, Dramamine motion sickness products, BC and Goody's Analgesic powders, Beano gas prevention, Gaviscon antacids, and Debrox ear drops. The Household Cleaning segment markets household cleaning products, such as Chore Boy scrubbing pads and sponges; Comet abrasive powders, creams, liquids, and non-abrasive sprays; and Spic and Span dilutables, sprays for counter tops, glass cleaners. Prestige Brands Holdings, Inc. distributes its products through various retail channels, including drug, grocery, dollar, and club stores, as well as supermarkets and mass merchandisers. The company was founded in 1996 and is headquartered in Irvington, New York.
Home Page: www.prestigebrands.com
PBH Technical Analysis
660 White Plains Road
Tarrytown,
NY
10591
United States
Phone:
914 524 6800
Officers
Name | Title |
---|---|
Mr. Ronald M. Lombardi | Chairman, Pres & CEO |
Ms. Christine Sacco | Chief Financial Officer |
Mr. Jeffrey Zerillo | Sr. VP of Operations |
Mr. William C. P'Pool | Sr. VP, Gen. Counsel & Corp. Sec. |
Mr. Adel Mekhail | Exec. VP of Marketing & Sales |
Mr. Philip David Terpolilli | Director of Investor Relations |
Dean Siegal | Director of Communications |
Ms. Mary Beth Fritz | Sr. VP of Quality & Regulatory Affairs |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 13.6054 |
---|---|
Trailing PE: | 15.7184 |
Price-to-Book MRQ: | 1.8629 |
Price-to-Sales TTM: | 2.7031 |
IPO Date: | 2005-02-10 |
Fiscal Year End: | March |
Full Time Employees: | 535 |